LCN2 and asthma: This study identifies a novel pathway by which PM<sub>2.5</sub> promotes asthma pathogenesis by activating the Fos-related antigen 2 (Fra2)/Lipocalin 2 (LCN2) axis, thereby inducing ferroptosis in M2 macrophages.